Piskel Kyle

Chief Financial Officer | Principal Accounting Officer

1 company

Weak

Trades Analyzed

12M Win Rate

20.0%

Avg 3M Return

-6.2%

Avg 12M Return

-59.6%

Piskel Kyle is a Chief Financial Officer at Adaptive Biotechnologies Corporation. Recent SEC Form 4 filings include 0 buys and 12 sells.

Estimated insider holdings value: $3.6M based on current market prices.

Holdings by Company

ADPTMar 11, 2026

Current Shares259.8K

Value$3.56M

Net Activity-206,723

Bought: 0Sold: 206.7K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 11, 2026	ADPT Adaptive Biotechnologies Corporation	Chief Financial Officer	Sell	18,672	$13.17	$245,910.24	-6.7%	-	-
Jan 12, 2026	ADPT Adaptive Biotechnologies Corp	Chief Financial Officer	Sale+OE	4,290	$18.00	$77,220.00	-1.9%	-30.0%	-
Nov 28, 2025	ADPT Adaptive Biotechnologies Corp	Chief Financial Officer	Sale+OE	162,820	$19.50	$3,174,990.00	-42.9%	-16.3%	-
Nov 17, 2025	ADPT Adaptive Biotechnologies Corp	Chief Financial Officer	Sell	238	$14.05	$3,343.90	-	+15.2%	-
May 16, 2025	ADPT Adaptive Biotechnologies Corp	Chief Financial Officer	Sell	1,929	$8.89	$17,148.81	-0.7%	+42.8%	-
Mar 5, 2025	ADPT Adaptive Biotechnologies Corp	Chief Financial Officer	Sell	10,320	$6.98	$72,072.21	-1.2%	+23.8%	+98.3%
Nov 18, 2024	ADPT Adaptive Biotechnologies Corp	Chief Financial Officer	Sell	248	$4.98	$1,235.04	-0.2%	+76.7%	+193.8%
Mar 5, 2024	ADPT Adaptive Biotechnologies Corp	Principal Accounting Officer	Sell	7,727	$3.43	$26,503.61	-5.9%	-12.4%	+112.4%
Nov 16, 2023	ADPT Adaptive Biotechnologies Corp	Principal Accounting Officer	Sell	259	$4.13	$1,069.67	-0.3%	-2.2%	+26.1%
Mar 7, 2022	ADPT Adaptive Biotechnologies Corp	Principal Accounting Officer	Sell	220	$12.01	$2,642.20	-0.5%	-41.9%	-26.5%